Cargando…
Efficacy and Safety of Aflibercept Therapy for Diabetic Macular Edema: A Systematic Review and Meta-Analysis
PURPOSE: To assess the real-world efficacy and safety of aflibercept for the treatment of diabetic macular edema (DME). METHODS: A systematic search was conducted across multiple databases. Articles were included if participants had DME and received aflibercept treatment for a minimum of 52 ± 4 week...
Autores principales: | Santhakumaran, Sangeetha, Salimi, Ali, Brunetti, Vanessa C., Galic, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486998/ https://www.ncbi.nlm.nih.gov/pubmed/36147265 http://dx.doi.org/10.4103/joco.joco_308_21 |
Ejemplares similares
-
The efficacy and safety of aflibercept and conbercept in diabetic macular edema
por: Cai, Siwei, et al.
Publicado: (2018) -
One-year outcomes of Aflibercept for refractory diabetic macular edema in Bevacizumab nonresponders
por: Salimi, Ali, et al.
Publicado: (2021) -
Efficacy of switching therapy to aflibercept for patients with persistent diabetic macular edema: a systematic review and meta-analysis
por: Liu, Yilin, et al.
Publicado: (2020) -
The role of aflibercept in the management of diabetic macular edema
por: Chang, Andrew A, et al.
Publicado: (2015) -
The clinical utility of aflibercept for diabetic macular edema
por: Stewart, Michael W
Publicado: (2015)